Accessibility Menu
AdaptHealth logo

AdaptHealth(NASDAQ) AHCO

Market Cap$792.16MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2019)-39%
5 Year-77%
1 Year-39%
1 Month-45%
$5.81
+1.84%
+0.10Today
After hours$5.86+$0.05 (+0.95%)
AdaptHealth last closing stock price
MetricPriceDate
Last closeUSD 5.812026-08-14
AdaptHealth stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+2.11%USD 5.692026-08-07
1 month-45.14%USD 10.592026-07-15
3 month-45.5%USD 10.662026-05-15
Year to date-41.67%USD 9.962025-12-31
1 year-38.78%USD 9.492025-08-14
3 year-56.87%USD 13.472023-08-15
5 year-76.87%USD 25.122021-08-13
Since inception-39.48%USD 9.602019-11-11

AdaptHealth Financials at a Glance

Market Cap

$792.16MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$3.01B

Net Income (TTM)

-$228.23M

EPS (TTM)

-$1.68

P/E Ratio

-3.46

Dividend

$0.00

Beta (Volatility)

0.93 (Low)

Price

$5.81

Volume

2,351,306.342

Open

$5.70

Previous Close

$5.81

Daily Range

$5.69 - $5.91

52-Week Range

$5.21 - $13.43

Estimated Earnings Date

Nov 3, 2026

AHCO: Motley Fool Moneyball Superscore

50

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About AdaptHealth

AdaptHealth helps people manage health from home. It delivers medical equipment to millions of patients. These tools help people with chronic illnesses.

Delivering Health to Your Door

  • Sleep Health: Therapy equipment and supplies for sleep apnea, including machines and masks; accounts for 42% of net revenue in 2025.
  • Diabetes Health: Medical devices for managing blood sugar levels, such as continuous glucose monitors and insulin pumps.
  • Respiratory Health: Oxygen and home ventilation equipment for patients with lung diseases and chronic respiratory failure.
  • Wellness at Home: Essential medical supplies and durable equipment like hospital beds and wheelchairs for patients leaving the hospital.

Growth Through Integration

  • Established a centralized technology platform to help AdaptHealth quickly integrate newly acquired companies and realize cost savings.
  • Signed the One Big Beautiful Bill Act on July 4, 2025, which will introduce new Medicaid eligibility and enrollment requirements starting in 2027.
  • Utilized at-risk capitation arrangements, receiving a per member per month fee to manage healthcare services for specific insurance members.
  • Planned the resumption of the Medicare competitive bidding process in 2026, which may change reimbursement rates for several product categories.

What Sets AdaptHealth Apart?

The company maintains a massive distribution network of approximately 640 locations across 48 states to serve 4.3 million patients annually. Its proprietary OTL mobile technology automates delivery notifications and tracks patient satisfaction to improve operational efficiency.

A Look at the Numbers

  • Net revenue was $846.3 million in Q4 2025, down 1.2% from the previous year.
  • Net income turned negative at -$102.8 million in Q4 2025, a performance that worsened by 304.5% year-over-year.
  • Operating cash flow reached $183.2 million in Q4 2025, up 21.8% from Q4 2024.
  • Free cash flow hit $79.3 million in Q4 2025, an 8.5% increase over the prior year.

Bottom Line

AdaptHealth has evolved into a national leader in home healthcare by consolidating local providers and applying centralized technology to its operations. The company focuses on the growing demand for chronic disease management while navigating complex shifts in government reimbursement and Medicaid policy.

AI Generated • Apr 29, 2026

Industry

Healthcare Providers and Services

Employees

10,900

CEO

Suzanne Foster

Headquarters

Conshohocken, PA 19428, US

AHCO Financials

Key Financial Metrics (TTM)

Gross Margin

10.37%

Operating Margin

-0.31%

Net Income Margin

-7.58%

Return on Equity

-15.16%

Return on Capital

5.44%

Return on Assets

-5.26%

Earnings Yield

-28.90%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$792.16MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

136.34M

Volume

2.35M

Avg. Volume

2.19M

Financials (TTM)

Gross Profit

$312.09M

Operating Income

-$9.44M

EBITDA

$290.01M

Operating Cash Flow

$583.27M

Capital Expenditure

-$485.59M

Free Cash Flow

$97.68M

Cash & ST Invst.

$43.29M

Total Debt

$2.07B

AdaptHealth Performance Analysis

AdaptHealth annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 2,970,595,00021.0%
20232023-12-31USD 3,200,177,0007.7%
20242024-12-31USD 3,260,975,0001.9%
20252025-12-31USD 3,244,857,000-0.5%
AdaptHealth sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-301.8%
Q42025-12-3140.4%
Q12026-04-10-3.1%
Q22026-06-30-9.7%
AdaptHealth annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD 0.50-57.5%
20232023-12-31USD -5.06N/A
20242024-12-31USD 0.61N/A
20252025-12-31USD -0.52N/A
AdaptHealth sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-3060.0%
Q42025-12-31-556.3%
Q12026-04-1083.6%
Q22026-06-30-725.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$740.31M

+25.1%

Gross Profit

$104.21M

+293.3%

Gross Margin

14.08%

N/A

Market Cap

$792.16MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$72.68K

N/A

Employees

10,900

N/A

Net Income

-$133.93M

-1012.7%

EBITDA

-$16.18M

-110.4%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$43.29M

-36.9%

Total Debt

$2.07B

+5.9%

Accounts Receivable

$390.39M

-0.8%

Inventory

$105.48M

-29.1%

Long Term Debt

$2.00B

+5.9%

Short Term Debt

$63.49M

+6.4%

Return on Assets

-5.26%

N/A

Return on Invested Capital

-0.26%

N/A

Free Cash Flow

-$20.94M

-128.6%

Operating Cash Flow

$145.30M

-10.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BBNXBeta Bionics, Inc.
$17.57-2.82%
INMDInMode Ltd.
$15.15-0.33%
AMPHAmphastar Pharmaceuticals, Inc.
$20.91+3.62%
CVACCureVac N.V.
$4.66+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NUNu Holdings
$15.23+0.09%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$8.76+0.01%
ONDSOndas
$9.24+0.04%
SPCXSpace Exploration Technologies
$140.00-0.01%

Questions About AHCO

What is the current price of AdaptHealth?

AdaptHealth is trading at $5.81 per share.

What is the 52-week range for AdaptHealth?

Over the past 52 weeks, AdaptHealth has traded between $5.21 and $13.43.

How much debt does AdaptHealth have?

As of the most recent reporting period, AdaptHealth reported total debt of $2.07B.

How much cash does AdaptHealth have on hand?

AdaptHealth reported $43.29M in cash and cash equivalents in its most recent financial results.

What is AdaptHealth’s dividend yield?

AdaptHealth does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.